Showing 1 - 10 of 8,544
cannot detect a signi.cant contribution of fiscal policies in stabilizing the US economy. For instance, the 2007-2009 large …
Persistent link: https://www.econbiz.de/10011434680
The debate about the use of fiscal instruments for macroeconomic stabilization has regained prominence in the aftermath of the Great Recession, and the experience of a monetary union equipped with fiscal shock absorbers, such as the United States, has often been a reference. This paper enhances...
Persistent link: https://www.econbiz.de/10011999069
Persistent link: https://www.econbiz.de/10012114884
One of the main contributions of Modern Money Theory (MMT) has been to explain why monetarily sovereign governments have a very flexible policy space that is unconstrained by hard financial limits. Not only can they issue their own currency to pay public debt denominated in their own currency,...
Persistent link: https://www.econbiz.de/10010251586
Persistent link: https://www.econbiz.de/10012431948
This paper focuses on the trade–offs that central banks would face if they were to start tackling climate change. Disruptive natural events can hamper growth and capital accumulation, thereby affecting price and financial stability – elements for which central banks are responsible. Yet, the...
Persistent link: https://www.econbiz.de/10013405241
Persistent link: https://www.econbiz.de/10012304041
This paper, using a microfounded macroeconomic model that embeds the key features of the Greek economy, studies the … ECB, like the PEPP, for the Greek economy? Do they help the real economy and, if yes, by how much? What would have …
Persistent link: https://www.econbiz.de/10012650611
The present paper contains a brief presentation and analysis, in a historical perspective through the lens of the recent major crises, of the legal framework governing the European Economic and Monetary Union (EMU), as well as current developments and challenges ahead. It is structured in three...
Persistent link: https://www.econbiz.de/10014077291
The number of drugs approved by the FDA for treating cancer has increased substantially during the last 40 years. Moreover, cancer drug innovation has been accelerating: more than 8 times as many new cancer drugs were approved during 2005-2015 as were approved during 1975-1985 (66 vs. 8). During...
Persistent link: https://www.econbiz.de/10011735934